We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Doximity (DOCS) Registers a Bigger Fall Than the Market: Important Facts to Note
Read MoreHide Full Article
Doximity (DOCS - Free Report) ended the recent trading session at $33.63, demonstrating a -1.81% change from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 0.31%. Elsewhere, the Dow lost 0.25%, while the tech-heavy Nasdaq lost 1.38%.
Shares of the medical social networking site witnessed a gain of 20.85% over the previous month, beating the performance of the Medical sector with its gain of 2.58%, and the S&P 500's gain of 0.87%.
Investors will be eagerly watching for the performance of Doximity in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on November 5, 2026. The company is forecasted to report an EPS of $0.34, showcasing a 24.44% downward movement from the corresponding quarter of the prior year. Alongside, our most recent consensus estimate is anticipating revenue of $170.66 million, indicating a 1.27% upward movement from the same quarter last year.
For the full year, the Zacks Consensus Estimates project earnings of $1.33 per share and a revenue of $675.74 million, demonstrating changes of -12.5% and +4.79%, respectively, from the preceding year.
Investors should also take note of any recent adjustments to analyst estimates for Doximity. These revisions help to show the ever-changing nature of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Doximity is holding a Zacks Rank of #3 (Hold) right now.
With respect to valuation, Doximity is currently being traded at a Forward P/E ratio of 25.67. Its industry sports an average Forward P/E of 34.47, so one might conclude that Doximity is trading at a discount comparatively.
Investors should also note that DOCS has a PEG ratio of 14.92 right now. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. As of the close of trade yesterday, the Medical Info Systems industry held an average PEG ratio of 3.18.
The Medical Info Systems industry is part of the Medical sector. With its current Zacks Industry Rank of 93, this industry ranks in the top 38% of all industries, numbering over 250.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Doximity (DOCS) Registers a Bigger Fall Than the Market: Important Facts to Note
Doximity (DOCS - Free Report) ended the recent trading session at $33.63, demonstrating a -1.81% change from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 0.31%. Elsewhere, the Dow lost 0.25%, while the tech-heavy Nasdaq lost 1.38%.
Shares of the medical social networking site witnessed a gain of 20.85% over the previous month, beating the performance of the Medical sector with its gain of 2.58%, and the S&P 500's gain of 0.87%.
Investors will be eagerly watching for the performance of Doximity in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on November 5, 2026. The company is forecasted to report an EPS of $0.34, showcasing a 24.44% downward movement from the corresponding quarter of the prior year. Alongside, our most recent consensus estimate is anticipating revenue of $170.66 million, indicating a 1.27% upward movement from the same quarter last year.
For the full year, the Zacks Consensus Estimates project earnings of $1.33 per share and a revenue of $675.74 million, demonstrating changes of -12.5% and +4.79%, respectively, from the preceding year.
Investors should also take note of any recent adjustments to analyst estimates for Doximity. These revisions help to show the ever-changing nature of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Based on our research, we believe these estimate revisions are directly related to near-term stock moves. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Doximity is holding a Zacks Rank of #3 (Hold) right now.
With respect to valuation, Doximity is currently being traded at a Forward P/E ratio of 25.67. Its industry sports an average Forward P/E of 34.47, so one might conclude that Doximity is trading at a discount comparatively.
Investors should also note that DOCS has a PEG ratio of 14.92 right now. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. As of the close of trade yesterday, the Medical Info Systems industry held an average PEG ratio of 3.18.
The Medical Info Systems industry is part of the Medical sector. With its current Zacks Industry Rank of 93, this industry ranks in the top 38% of all industries, numbering over 250.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions.